<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p115" style="overflow: hidden; position: relative; background-color: white; width: 908px; height: 1286px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_115{left:130px;bottom:1195px;letter-spacing:0.2px;}
#t2_115{left:796px;bottom:1195px;letter-spacing:0.13px;}
#t3_115{left:238px;bottom:1115px;letter-spacing:-0.01px;}
#t4_115{left:238px;bottom:1096px;letter-spacing:-0.01px;}
#t5_115{left:238px;bottom:1076px;letter-spacing:-0.01px;}
#t6_115{left:128px;bottom:1032px;letter-spacing:-0.21px;}
#t7_115{left:238px;bottom:1031px;letter-spacing:0.17px;}
#t8_115{left:141px;bottom:992px;letter-spacing:-0.01px;}
#t9_115{left:237px;bottom:992px;letter-spacing:-0.01px;}
#ta_115{left:143px;bottom:935px;letter-spacing:-0.29px;}
#tb_115{left:239px;bottom:955px;letter-spacing:-0.01px;}
#tc_115{left:239px;bottom:936px;letter-spacing:-0.01px;}
#td_115{left:237px;bottom:900px;letter-spacing:-0.04px;}
#te_115{left:238px;bottom:846px;letter-spacing:-0.01px;}
#tf_115{left:238px;bottom:827px;letter-spacing:-0.01px;}
#tg_115{left:238px;bottom:807px;letter-spacing:-0.01px;}
#th_115{left:238px;bottom:788px;letter-spacing:-0.01px;}
#ti_115{left:238px;bottom:768px;letter-spacing:-0.01px;}
#tj_115{left:238px;bottom:720px;letter-spacing:-0.01px;}
#tk_115{left:238px;bottom:701px;letter-spacing:-0.01px;}
#tl_115{left:238px;bottom:682px;letter-spacing:-0.01px;}
#tm_115{left:238px;bottom:662px;letter-spacing:-0.01px;}
#tn_115{left:238px;bottom:643px;letter-spacing:-0.01px;}
#to_115{left:238px;bottom:623px;letter-spacing:-0.01px;}
#tp_115{left:238px;bottom:604px;letter-spacing:-0.01px;}
#tq_115{left:238px;bottom:556px;letter-spacing:-0.01px;}
#tr_115{left:320px;bottom:556px;letter-spacing:-0.01px;}
#ts_115{left:238px;bottom:536px;letter-spacing:-0.01px;}
#tt_115{left:238px;bottom:517px;letter-spacing:-0.01px;}
#tu_115{left:238px;bottom:497px;letter-spacing:-0.01px;}
#tv_115{left:128px;bottom:444px;letter-spacing:-0.17px;}
#tw_115{left:238px;bottom:444px;letter-spacing:-0.17px;}
#tx_115{left:238px;bottom:422px;letter-spacing:-0.01px;}
#ty_115{left:238px;bottom:402px;letter-spacing:-0.01px;}
#tz_115{left:238px;bottom:383px;letter-spacing:-0.01px;}
#t10_115{left:238px;bottom:364px;letter-spacing:-0.01px;}
#t11_115{left:238px;bottom:296px;letter-spacing:-0.01px;}
#t12_115{left:238px;bottom:277px;letter-spacing:-0.01px;}
#t13_115{left:238px;bottom:229px;letter-spacing:-0.01px;}
#t14_115{left:238px;bottom:209px;letter-spacing:-0.01px;}
#t15_115{left:238px;bottom:190px;letter-spacing:-0.01px;}
#t16_115{left:238px;bottom:170px;letter-spacing:-0.01px;}
#t17_115{left:238px;bottom:151px;letter-spacing:-0.01px;}
#t18_115{left:202px;bottom:69px;letter-spacing:0.23px;}

.s0_115{font-size:11px;font-family:NotoSans-Regular_7j-;color:#000;}
.s1_115{font-size:12px;font-family:NotoSans-Regular_7j-;color:#000;}
.s2_115{font-size:13px;font-family:NotoSans-Regular_7j-;color:#000;}
.s3_115{font-size:15px;font-family:NotoSans-Regular_7j-;color:#000;}
.s4_115{font-size:28px;font-family:NotoSans-Regular_7j-;color:#000;}
.s5_115{font-size:10px;font-family:NotoSans-Regular_7j-;color:#000;}
.s6_115{font-size:13px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.s7_115{font-size:21px;font-family:NotoSans-Regular_7j-;color:#000;}
.s8_115{font-size:21px;font-family:NotoSans-Regular_7j-_1;color:#000;}
.s9_115{font-size:11px;font-family:NotoSans-Regular_7j-_1;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts115" type="text/css" >

@font-face {
	font-family: NotoSans-Regular_7j-;
	src: url("fonts/NotoSans-Regular_7j-.woff") format("woff");
}

@font-face {
	font-family: NotoSans-Regular_7j-_1;
	src: url("fonts/NotoSans-Regular_7j-_1.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg115Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg115" style="-webkit-user-select: none;"><object width="908" height="1286" data="115/115.svg" type="image/svg+xml" id="pdf115" style="width:908px; height:1286px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_115" class="t s0_115">7.11. Palliative therapy </span><span id="t2_115" class="t s1_115">115 </span>
<span id="t3_115" class="t s2_115">an artificial form of nutrition, nasogastric tube or PEG is indicated. If everything goes well, </span>
<span id="t4_115" class="t s2_115">oral training can then be started, possibly with drop by drop water and small amounts of </span>
<span id="t5_115" class="t s2_115">mashed potatoes. </span>
<span id="t6_115" class="t s3_115">7.10.4.2. </span><span id="t7_115" class="t s3_115">PEG </span>
<span id="t8_115" class="t s2_115">7.77. </span><span id="t9_115" class="t s2_115">Consensus-based recommendation </span>
<span id="ta_115" class="t s4_115">EEC </span>
<span id="tb_115" class="t s2_115">A PEG should only be inserted if it is expected that tube feeding will be </span>
<span id="tc_115" class="t s2_115">necessary for a longer period of time. </span>
<span id="td_115" class="t s5_115">Strong consensus: 100% </span>
<span id="te_115" class="t s2_115">After extensive partial laryngectomies and after total laryngectomies, the insertion of a </span>
<span id="tf_115" class="t s2_115">nasogastric tube is necessary in the postoperative healing phase. Primary treatment with a PEG </span>
<span id="tg_115" class="t s2_115">is generally not recommended in these cases, as is the case with salvage surgery. If dysphagia </span>
<span id="th_115" class="t s2_115">and especially aspiration continue to occur after the healing phase and intensive swallowing </span>
<span id="ti_115" class="t s2_115">training, the nasogastric tube should be replaced with a PEG. </span>
<span id="tj_115" class="t s2_115">The nasogastric tube is always moved during swallowing and can secondarily impair the motility </span>
<span id="tk_115" class="t s2_115">of the pharyngeal structures and swallowing training. In addition to the foreign body sensation </span>
<span id="tl_115" class="t s2_115">and avoidance of swallowing, the velopharyngeal closure and the closure of the upper </span>
<span id="tm_115" class="t s2_115">esophageal sphincter are no longer physiologically present. This can change the </span>
<span id="tn_115" class="t s2_115">intrapharyngeal pressure during swallowing and nasal penetration and regurgitation of gastric </span>
<span id="to_115" class="t s2_115">juice become possible. A PEG reduces these secondary symptoms and improves the conditions </span>
<span id="tp_115" class="t s2_115">for further swallowing training. </span>
<span id="tq_115" class="t s2_115">The patient's </span><span id="tr_115" class="t s6_115">pre-therapeutic nutritional status, general condition and adherence must also </span>
<span id="ts_115" class="t s6_115">be taken into account when choosing artificial nutrition. This particularly includes the </span>
<span id="tt_115" class="t s6_115">placement of a PEG in cases of poor nutritional status and general condition before starting </span>
<span id="tu_115" class="t s2_115">radio(chemo)therapy. </span>
<span id="tv_115" class="t s7_115">7.11. </span><span id="tw_115" class="t s8_115">Palliative therapy </span>
<span id="tx_115" class="t s6_115">Palliative care is defined as an approach to improving the quality of life of patients and their </span>
<span id="ty_115" class="t s6_115">families facing problems associated with a life-threatening illness [406] by preventing and </span>
<span id="tz_115" class="t s6_115">alleviating suffering through early detection, careful assessment and treatment of pain and </span>
<span id="t10_115" class="t s6_115">other physical, psychosocial and spiritual problems. </span>
<span id="t11_115" class="t s6_115">Regarding palliative medicine aspects, regardless of the underlying diagnosis, reference is </span>
<span id="t12_115" class="t s6_115">made to the S3 guideline on palliative medicine of the oncology guideline program [407]. </span>
<span id="t13_115" class="t s6_115">Palliative (tumor) therapies are medicinal and non-medicinal measures directed against the </span>
<span id="t14_115" class="t s6_115">underlying disease in patients with an incurable disease with the primary goal of prolonging </span>
<span id="t15_115" class="t s6_115">life and/or controlling symptoms (e.g. radiotherapy, surgical procedures, medicinal tumor </span>
<span id="t16_115" class="t s6_115">therapies) and/or improving quality of life. They relate to tumor biology and are therefore </span>
<span id="t17_115" class="t s2_115">tumor-specific. </span>
<span id="t18_115" class="t s9_115">Â© Oncology Guideline Program | S3 Guideline Laryngeal Carcinoma | Long Version 1.0 | January 2019 </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
